Time-dependent associations between iron and mortality in hemodialysis patients.
about
Serum ferritin: Past, present and futureIatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturySafety concerns about intravenous iron therapy in patients with chronic kidney diseaseConsiderations and challenges in defining optimal iron utilization in hemodialysisEfficiency of Original versus Generic Intravenous Iron Formulations in Patients on HaemodialysisSafety of intravenous iron in hemodialysis patients.High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patientsA multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistencyAssociation of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease.Effect of electronic patient record use on mortality in End Stage Renal Disease, a model chronic disease: retrospective analysis of 9 years of prospectively collected data.The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected dataHFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.Intravenous iron exposure and mortality in patients on hemodialysisSerum iron markers are inadequate for guiding iron repletion in chronic kidney diseaseIntravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patientsThe A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.Iron supplementation and mortality in incident dialysis patients: an observational study.Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.Correction of iron deficiency in the cardiorenal syndromeIntravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patientsEffect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry.Iron metabolism and iron supplementation in cancer patientsThe kidney disease wasting: inflammation, oxidative stress, and diet-gene interaction.Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis PatientsIntravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patientsErythropoiesis-stimulating agent hyporesponsiveness.Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality?Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation.Infection risk with bolus versus maintenance iron supplementation in hemodialysis patientsThe role of intravenous iron in anemia management and transfusion avoidance.Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patientsIron Indices in Patients with Functional Anemia in Chronic Kidney Disease.Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
P2860
Q24626621-8B2A57E4-A22A-4276-A72A-68B82FCA16A8Q26752664-5C5D75A7-5B8F-4DC2-AD81-333EAAF1AE8FQ26764881-669EEC39-6929-4132-AFE1-7E632826F539Q28088564-6C586729-24C8-4521-B413-304DE84DCEBFQ28547636-CC75BF45-E087-4CDB-8D86-6238605A1C14Q30234981-93E047C4-4842-45AA-B0CE-323D5AAED5AEQ30425078-16475189-D541-4B3E-AC2A-7C0A9D469491Q30430605-78C9AED5-B42A-43DC-8A6D-EC4D5ACB0018Q30437163-8B3E3294-1525-4D0B-92B1-1B994C9BE170Q31138083-BC11163B-B042-4A21-8EA7-1490AF09F460Q33412890-6B05F7E5-D38B-4D7A-A297-C581E48A411CQ33471093-1B960EBB-521A-4726-82AE-A84DC03360E1Q33832885-6E5F9C1B-D343-4A53-9A13-5D2062A75C32Q33881779-851F25CB-D04D-48B8-959A-69B9784DF224Q34427619-62855C56-A591-45BD-9489-6FEFA9749CA8Q34455198-65D82601-71A4-46DC-A104-241A484F18E0Q34497292-3A46E740-D581-495F-920E-5E0EC3330BDCQ34506972-ADD47552-45C9-4A43-8BCA-54A3956AAD43Q34513137-59213D44-3174-44BF-B33B-6A9E2EEC5CC5Q34596298-39E25ABA-B8BA-4F70-B7E3-485417ED8982Q34612274-D9C2135E-D1D6-4F2B-8DDE-22B5489C50D9Q34704499-B3C907C0-D723-4984-A18D-CEF0D5FE04A8Q34989324-5803AEE2-817B-42CC-80E3-C857AB45E915Q35041088-F6C8C92D-3E1C-4724-BCC3-8EC291ABE6F9Q35474305-E589EDFC-DF07-4C1F-8F96-68C3C4E06E9AQ35849765-9D1132F2-A9F8-4112-A314-EF429E824F14Q36371665-92B9B835-A204-49C8-B96D-683B50BB461AQ36609845-CD0FD3BB-D149-49DF-9630-BE22AD8ED6ADQ36677375-489E5E09-AECF-4C1C-96A8-5B9D313B182BQ36736105-C0831C7C-160D-4D08-98BA-8EE249AF4C74Q36746098-DEC9FBCD-1713-418D-AC2F-795AAD0B2A87Q36842398-ACA7CED6-5AF8-40ED-B404-C026DF730ADBQ36884461-AC27FCF8-E486-4C1B-852A-83CD2E7AF943Q36925390-CA31A4B4-8111-4B2F-B21D-3F6CA4FF8CD8Q36947373-602AF6A3-180A-4C7C-815F-389CB9921862Q36977382-05F5EE58-6D28-42FB-B72B-F1D71E39F8EFQ37111927-8FC0E213-B389-4F68-8FFD-2176F64AFF7BQ37123216-BC4DEEA2-7363-4EFB-9B11-8F21899C01E9Q37155059-7B38955A-39CB-4055-81C4-B036E012A0D8Q37164472-5F96E668-0193-46E9-80BD-6536D1DA40F4
P2860
Time-dependent associations between iron and mortality in hemodialysis patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Time-dependent associations between iron and mortality in hemodialysis patients.
@en
Time-dependent associations between iron and mortality in hemodialysis patients.
@nl
type
label
Time-dependent associations between iron and mortality in hemodialysis patients.
@en
Time-dependent associations between iron and mortality in hemodialysis patients.
@nl
prefLabel
Time-dependent associations between iron and mortality in hemodialysis patients.
@en
Time-dependent associations between iron and mortality in hemodialysis patients.
@nl
P2093
P356
P1476
Time-dependent associations between iron and mortality in hemodialysis patients.
@en
P2093
Beckie Michael
Charles J McAllister
David G Warnock
Deborah L Regidor
P304
P356
10.1681/ASN.2005040423
P577
2005-07-20T00:00:00Z